Former CEO of Lorillard Tobacco Joins BAT's Board of Directors
According to a news report from Journalnow on October 5th, the board of directors of British American Tobacco (BAT) has announced the appointment of Murray Kessler, former CEO of Lorillard Tobacco, as an independent director on November 6th. Kessler served as Chairman and CEO of Lorillard from 2010 to June 2015, when it was acquired by Reynolds American for $29.25 billion.
After Renault USA's acquisition of Lararald, Kessler joined the board of directors. Recently, Kessler assumed the roles of CEO and President at Perrigo Public Limited Company. His previous experience in the tobacco industry includes serving as Chairman, CEO, and President at UST (United States Tobacco).
Luc Jobin, Chairman of British American Tobacco, stated in a declaration, "'A Better Tomorrow' is a new initiative launched by British American Tobacco in 2019. The focus of this plan is primarily on new category products, including the best-selling e-cigarette, Vuse, in the United States, the heat-not-burn product, glo (not yet available in the US), and the oral products, Camel Snus and Velo."
British American Tobacco (BAT) has recently undergone multiple personnel changes. Guy Meldrum, the former President and CEO of BAT subsidiary Reynolds American, resigned on June 30th, and David Waterfield assumed his position on July 1st. Tadeu Marroco took over as CEO of BAT on May 15th, replacing Jack Bowles, who unexpectedly and immediately resigned from his roles as President and CEO after serving for four years.
The British media is tracing the reasons behind the unexpected resignation of Mr. Bowles and points out that this may be related to the disclosure by British American Tobacco on April 26, 2023, of their agreement to pay a civil penalty of $508 million to settle "allegations of selling tobacco to North Korea in violation of (US) sanctions.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
